2018
DOI: 10.1158/1078-0432.ccr-17-3855
|Get access via publisher |Cite
|
Sign up to set email alerts

D-2-Hydroxyglutarate Is an Intercellular Mediator in IDH-Mutant Gliomas Inhibiting Complement and T Cells

Abstract: Somatic mutations in the isocitrate dehydrogenase (IDH)-1 and -2 genes are remarkably penetrant in diffuse gliomas. These highly effective gain-of-function mutations enable mutant IDH to efficiently metabolize isocitrate to D-2-hydroxyglutarate (D 2-HG) that accumulates to high concentrations within the tumor microenvironment. D 2-HG is an intracellular effector that promotes tumor growth through widespread epigenetic changes in IDH-mutant tumor cells, but its potential role as an intercellular immune regulato… Show more (VSports app下载)

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

6
61
1

Year Published

2018
2018
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations

Cited by 81 publications

(68 citation statements)
references

References V体育ios版 - 45 publications

6
61
1
Order By: Relevance